Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

More exercise might link to hair loss, but other factors also matter.

Beard hair extraction improves scalp hair restoration results in East Asian men with severe hair loss.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

Hair loss doesn't affect COVID-19 severity.

Men with hair loss are more likely to experience moderate to severe COVID-19 symptoms.

Hair loss link to COVID-19 severity likely due to other factors.

Finger length ratio may indicate male hair loss.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

1 mg/day oral finasteride significantly improves hair growth in men with male pattern baldness.

More men than women have hair loss, it's often inherited, and it's linked with higher testosterone levels. There's been a rise in female hair loss patients.

Sparse hairs below frontal hairline can indicate early male balding.

Male pattern baldness is common, affects quality of life, and new treatments like Propecia show promise.

Using a carbon dioxide laser and platelet-rich plasma together can effectively restore hair and patients are generally satisfied with the results.

Unhealthy lifestyle and diet may increase the risk of early hair loss in young men.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Nanofat injections can significantly improve hair growth in men with hair loss for up to a year.

Valproic acid can cause hair loss when taken orally but may promote hair growth when applied topically.

Fat cells near hair follicles may affect hair growth and could help treat baldness.

Platelet Rich Plasma (PRP) therapy can improve hair thinning in male pattern baldness patients, but more research is needed to confirm its effectiveness.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

The document concludes that more research is needed to create specific drugs for treating male pattern baldness.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

A rare ovarian tumor caused high testosterone, hair loss, and missed periods, but surgery fixed these issues and led to pregnancy.